Polymorphic form inconsistency during stability studies – regulatory impact assessment
Detecting polymorphic form inconsistencies begins with observing specific symptoms during stability studies:Click to read the full article.
Tips for Raw Materials & Excipients Management
Residual solvent excursions during deviation investigation – regulatory impact assessment
Detecting residual solvent excursions begins with recognizing signals on the production floor or in the laboratory. Symptoms can manifest in various ways: unexpected changes in product characteristics, deviations noted during…
Polymorphic form inconsistency during supplier change – inspection questions regulators ask
The initial signs of polymorphic form inconsistency may manifest in various ways, often noticed during routine quality control testing or production processes. Key symptoms include:Click to read the full article.
Particle size variability impacts performance during supplier change – inspection questions regulators ask
Identifying symptoms of particle size variability early is crucial for effective investigation and resolution. Key symptoms might include:Click to read the full article.
Variability in excipient grade during scale-up – regulatory scrutiny of excipient data
The identification of symptoms related to variability in excipient grade is the first critical step in effectively managing and investigating the issue. Symptoms may manifest in various ways, impacting both…
Unjustified excipient choice during formulation development – CAPA for formulation failures
The first step in any investigation is recognizing the symptoms or signals that indicate a potential issue with excipient selection. These symptoms may manifest in numerous ways:Click to read the…
Functional performance failure during stability assessment – preventing late-stage reformulation
Identifying symptoms of functional performance failures early in the stability assessment process is crucial for timely intervention. Common signals include:Click to read the full article.
Variability in excipient grade during formulation development – compatibility study expectations
In any pharmaceutical development setting, spotting deviations early can save extensive resources and time. Symptoms of variability in excipient grades may manifest as:Click to read the full article.
Variability in excipient grade during regulatory review – CAPA for formulation failures
Identifying symptoms is the first step in addressing the variability in excipient grades. Symptoms can arise from several indicators, and catching these early is crucial for timely intervention. Common signals…
Functional performance failure during stability assessment – regulatory scrutiny of excipient data
Identifying symptoms or signals of functional performance failure early is critical to mitigating regulatory risks. Symptoms may manifest as:Click to read the full article.
Supplier grade substitution during supplier qualification – compatibility study expectations
Identifying early warning signs of issues arising from supplier grade substitutions is pivotal in safeguarding product quality. Symptoms can surface at various stages, including:Click to read the full article.
Variability in excipient grade during supplier qualification – risk assessment for excipient choice
The first step in managing excipient variability is recognizing the symptoms or signals that indicate potential issues on the manufacturing floor or in the laboratory. Some common signs include:Click to…